EGA Q&A on the Revised EMA Bioequivalence Requirement

To view the full report, please click here.

IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
Why Clarification & Harmonisation of the Bolar Exemption and… 31 October 2023 The revised Pharmaceutical Legislation must deliver more access to medicines,…
Harmonised bioequivalence guideline paves the way for global… 26 April 2023 Open
Position on the Proposal for a Regulation of the European… 19 June 2023 Medicines for Europe welcomes the introduction of harmonised labelling, notably…